Invacare Corporation logo
Invacare Corporation IVC

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Invacare Corporation Financial Statements 2011-2026 | IVC

Annual Financial Statements Invacare Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

24.1 M 78.5 M 321 M 274 M 173 M 606 M 369 M 496 M 469 M 681 M 533 M 536 M

Shares

36.5 M 34.9 M 34.3 M 33.6 M 33.1 M 32.8 M 32.5 M 32.2 M 32 M 31.9 M 31.6 M 32 M

Historical Prices

0.66 2.25 9.36 7.66 5.08 18.1 11.3 15.1 14.3 19.6 15.2 16.5

Net Income

-20.6 M 1.94 M -28.3 M -53.3 M -43.9 M -76.5 M -42.9 M -26.2 M -56.1 M 33.1 M 1.83 M -4.11 M

Revenue

181 M 226 M 851 M 928 M 972 M 966 M 1.05 B 1.14 B 1.27 B 1.35 B 1.46 B 1.8 B

Cost of Revenue

566 M 633 M 605 M 666 M 705 M 697 M 764 M 830 M 923 M 967 M 989 M -

Gross Profit

48.3 M 63.3 M 245 M 262 M 268 M 269 M 284 M 313 M 347 M 377 M 445 M 518 M

Operating Income

-80.5 M -24.2 M 11.3 M -10.4 M -18.3 M -40.2 M -15.2 M -7.77 M -58.8 M - - -

Interest Expense

28.5 M 24.3 M 28.5 M 29.1 M 28.3 M 22.9 M 15.9 M 4.14 M 4.89 M 3.08 M 7.74 M -8.89 M

EBITDA

-65 M -7.41 M 25.6 M 26.5 M 1.33 M -12.9 M -5.52 M 12.4 M -3.74 M 12.4 M 69 M 111 M

Operating Expenses

- - - 260 M 282 M 297 M 304 M 320 M 384 M 402 M 415 M 446 M

General and Administrative Expenses

227 M 232 M 236 M 260 M 282 M 297 M 304 M 320 M 384 M 402 M 415 M 422 M

All numbers in USD currency

Quarterly Income Statement Invacare Corporation

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

38 M - 37.5 M 35.6 M 35 M - 35 M 35 M 34.5 M - 34.4 M 34.4 M 34.1 M - 33.7 M 33.7 M 33.3 M - 33.2 M 33.2 M 32.9 M - 32.9 M 32.8 M 32.5 M - 32.5 M 32.2 M 32.4 M - 32.2 M 32.1 M 32.1 M - 32 M 32 M 32 M - 31.9 M 31.9 M 31.9 M - 31.9 M 31.8 M 31.8 M - 31.9 M 32 M 32.2 M

Net Income

-41.2 M - -34.4 M -21.9 M -24.2 M 1.94 M -22.8 M -10.7 M -14 M -5.12 M -7.28 M -16.6 M -16.6 M -18.7 M -8.04 M -12.7 M -13.9 M -1.24 M -12 M -16.5 M -14.1 M -17.7 M -18.6 M -23.5 M -16.8 M -17.6 M -5.02 M -11.6 M -8.62 M -2.93 M -7.79 M -8.22 M -7.25 M -9.38 M -15.1 M -13.6 M -18 M -5.77 M 16.1 M -12.5 M 35.2 M -7.29 M 2.86 M -1.98 M 8.23 M -35 M 12.8 M 10.7 M 7.45 M

Revenue

165 M - 170 M 189 M 201 M 226 M 224 M 226 M 196 M 224 M 212 M 196 M 196 M 233 M 113 K 119 K 129 K 245 M 85 K 136 K 249 K 250 M 137 K 49 K 88 K 247 M 79 K 74 K 54 K 283 M 42 K 42 K 38 K 318 M 38 K 323 K 68 K 331 M 58 K 74 K 107 K 355 M 166 K 143 K 301 K 374 M 625 K 279 K 267 K

Cost of Revenue

122 M - 139 M 141 M 153 M - 164 M 165 M 142 M - 152 M 140 M 295 M - 168 M 171 M 162 M - 179 M 179 M 171 M - 180 M 168 M 167 M - 195 M 201 M 190 M - 206 M 209 M 212 M - 236 M 235 M 222 M - 242 M - - - - - - - - - -

Gross Profit

43.8 M - 31.4 M 48 M 47.7 M 63.3 M 60.3 M 60.8 M 54.6 M 65.6 M 60 M 56.6 M 56.6 M 68 M 67.6 M 65.1 M 61.5 M 68.2 M 65.6 M 67.3 M 66.5 M 68.3 M 70.7 M 65 M 65.1 M 68.7 M 73.4 M 73.6 M 67.9 M 80.8 M 77.6 M 77.3 M 77.1 M 88.4 M 84.6 M 91.6 M 82.8 M 91.3 M 94.2 M 90.9 M 91 M 105 M 109 M 113 M 109 M 120 M 122 M 125 M 114 M

Operating Income

-10.4 M - -33.4 M -14.8 M -16.6 M - -24.8 M -3.49 M -5.74 M - 2.93 M -2.24 M 7.21 M - 2.42 M -4.51 M -4.48 M - -5.28 M -6.76 M -5.15 M - -5.88 M -15.7 M -10.7 M - 2.62 M -5.82 M -5.08 M - 189 K -5.82 M -4.38 M - - - - - - - - - - - - - - - -

Interest Expense

9.1 M - 7.35 M 6.23 M 6.25 M - 6.28 M 6.08 M 5.73 M - 7.4 M 7.05 M 13.7 M - 6.99 M 7.72 M 7.31 M - 7.12 M 6.96 M 6.96 M - 6.84 M 4.64 M 4.52 M - 4.48 M 4.37 M 2.37 M - 1.02 M 710 K 692 K - 549 K 1.05 M 689 K - 639 K -741 K -1.01 M - -1.95 M -2.16 M -2.05 M - -1.02 M -1.95 M -2.34 M

EBITDA

-6.88 M - -21.6 M -6.95 M -12.7 M - -12.3 M 4.77 M -1.66 M - 13.3 M -2.24 M 13.9 M - 14.2 M 3.3 M -580 K - 6.7 M 939 K -1.04 M - 5.07 M -8.37 M -7.06 M - 13.5 M 1.45 M -1.42 M - 13.8 M 4.62 M 968 K - 26.4 M 18.2 M 9.51 M - 28.2 M 18.9 M 8.85 M - 29.1 M 19.4 M 9.63 M - 27.6 M 18.1 M 8.8 M

General and Administrative Expenses

53.8 M - 55.4 M 58.6 M 60.6 M - 56.1 M 63.8 M 58.8 M - 55.5 M 57.4 M 119 M - 63.5 M 68.3 M 65.2 M - 69.9 M 73.8 M 71.3 M - 75.9 M 75.7 M 72.5 M - 77.7 M 78.7 M 72.8 M - 77.5 M 82.4 M 81.2 M - 98.2 M 100 M 96.8 M - 97.6 M 104 M 103 M - 103 M 104 M 101 M - 104 M 112 M 106 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Invacare Corporation IVC
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Invacare Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.35 - $ 21.8 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.72 -1.26 % $ 464 M curacaoCuracao
LENSAR LENSAR
LNSR
$ 5.56 -8.4 % $ 64 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 32.61 2.71 % $ 1.5 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.56 -0.19 % $ 1.13 B usaUSA
Penumbra Penumbra
PEN
$ 334.17 -0.41 % $ 13 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
$ 24.7 0.86 % $ 209 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Insulet Corporation Insulet Corporation
PODD
$ 225.5 -0.7 % $ 15.9 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.7 3.3 % $ 38.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.16 -6.09 % $ 3.37 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.15 -4.63 % $ 180 M canadaCanada
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.82 -3.05 % $ 163 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.48 10.7 % $ 1.55 B usaUSA
Myomo Myomo
MYO
$ 0.7 -1.83 % $ 29.3 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 2.4 -1.64 % $ 141 M israelIsrael
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.91 4.83 % $ 146 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.91 -3.4 % $ 373 M usaUSA
Outset Medical Outset Medical
OM
$ 3.53 -2.35 % $ 53.7 K usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 52.07 -0.17 % $ 1.53 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.57 0.78 % $ 7.13 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.31 -5.76 % $ 53.3 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.96 -3.65 % $ 64.7 M usaUSA
InspireMD InspireMD
NSPR
$ 1.79 3.47 % $ 115 M israelIsrael
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA